Skip to main content
. 2022 Nov 15;16:1042814. doi: 10.3389/fnins.2022.1042814

FIGURE 7.

FIGURE 7

The cross-sectional study (left) observed reduced anterior cingulate cortex glutathione (GSH) levels and hippocampus volumes in non-responders; however, the longitudinal study data (right) found that anterior cingulate cortex GSH and hippocampus volume are stable over time in patients; these results imply that anterior cingulate cortex GSH and hippocampus volume may be trait markers for non-responders. Studying data from multimodal longitudinal cohorts may be a promising approach in the future to identify biomarkers for schizophrenia or a subset of schizophrenia patients. This figure shows anterior cingulate cortex GSH levels and the HP volume as potential biomarkers for TR to antipsychotics (Zhao et al., 2019; Picó-Pérez et al., 2022). Future studies are expected to identify additional biomarkers for TR and a combination of multimodal biomarkers that may be useful for the early diagnosis of TR in the clinic.